BioXpress Therapeutics ^Company

BioXpress Therapeutics SA is a company based in Geneva, Switzerland that specializes in providing high-quality biologic APIs for unmet need indications such as cancer, inflammation, and autoimmunity. The company is focused on developing biosimilar monoclonal antibodies in many different countries and currently has five programs in development, two of which are partnered with worldwide rights. They are seeking alliances with other biopharmaceutical companies and health organizations to accelerate the development of biosimilar therapeutics. The company is rapidly advancing its biosimilars pipeline as the MAb-based drug market is one of the fastest growing categories of the biopharmaceuticals industry.